Article
Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.
PloS one - 1 Jan 2014
Yeh Ming-Lun, Huang Chung-Feng, Huang Ching-I, Liu Shu-Fen, Yang Hua-Ling, Hsieh Ming-Yen, Huang Jee-Fu, Dai Chia-Yen, Chuang Wan-Long, Yu Ming-Lung
Abstract excerpt
BACKGROUND: Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There is little information whether there is detection difference in drug resistant mutations between different viral load assays of HBV. OBJECTIVES: This study is aimed to investigate whether there is drug-resistant strains related detection difference between Abbott RealTime HBV (RealTime) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.